Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas

[1]  M. Köbel,et al.  Immunophenotypic features of dedifferentiated endometrial carcinoma – insights from BRG1/INI1‐deficient tumours , 2016, Histopathology.

[2]  A. Malpica,et al.  Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[3]  Chengquan Zhao,et al.  Clinicopathologic and Immunohistochemical Characterization of Dedifferentiated Endometrioid Adenocarcinoma , 2016, Applied immunohistochemistry & molecular morphology : AIMM.

[4]  D. Huntsman,et al.  Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas , 2016, Modern Pathology.

[5]  J. Trent,et al.  Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type , 2015, The Journal of pathology.

[6]  M. Köbel,et al.  Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases , 2015, The American journal of surgical pathology.

[7]  M. Crook,et al.  SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma , 2015, Pathology.

[8]  M. Beckmann,et al.  Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. , 2015, Annals of diagnostic pathology.

[9]  G. Crabtree,et al.  Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics , 2015, Science Advances.

[10]  D. Huntsman,et al.  Targeted mutation analysis of endometrial clear cell carcinoma , 2015, Histopathology.

[11]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[12]  Ling Chen,et al.  Low-grade endometrioid carcinoma of the ovary associated with undifferentiated carcinoma: case report and review of the literature. , 2014, International journal of clinical and experimental pathology.

[13]  Chengquan Zhao,et al.  Molecular Characterization of Undifferentiated Carcinoma Associated With Endometrioid Carcinoma , 2014, The American journal of surgical pathology.

[14]  D. Huntsman,et al.  Immunohistochemical characterization of prototypical endometrial clear cell carcinoma—diagnostic utility of HNF‐1β and oestrogen receptor , 2014, Histopathology.

[15]  W. Hahn,et al.  ARID1B is a specific vulnerability in ARID1A-mutant cancers , 2014, Nature Medicine.

[16]  C. Roberts,et al.  Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers , 2014, Proceedings of the National Academy of Sciences.

[17]  J. Yokota,et al.  A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. , 2013, Cancer research.

[18]  T. S. Patrelli,et al.  Dedifferentiated endometrial cancer: an atypical case diagnosed from cerebellar and adrenal metastasis: case presentation and review of literature. , 2013, International journal of clinical and experimental pathology.

[19]  Zhengyan Kan,et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.

[20]  Meng Li,et al.  Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types , 2011, Human mutation.

[21]  M. Bisceglia,et al.  Dedifferentiated Endometrioid Adenocarcinoma of the Uterus , 2011, International journal of surgical pathology.

[22]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[23]  R. Bristow,et al.  “Contextual” Synthetic Lethality and/or Loss of Heterozygosity: Tumor Hypoxia and Modification of DNA Repair , 2010, Clinical Cancer Research.

[24]  L. Tafe,et al.  Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms , 2010, Modern Pathology.

[25]  A. Malpica,et al.  Undifferentiated carcinoma of the endometrium: a review. , 2007, Pathology.

[26]  D. Bodurka,et al.  Association of Low-Grade Endometrioid Carcinoma of the Uterus and Ovary With Undifferentiated Carcinoma: A New Type of Dedifferentiated Carcinoma? , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[27]  Weidong Wang,et al.  Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. , 2003, Cancer research.